Brad Canino
Stock Analyst at Guggenheim
(3.44)
Main Sectors:
Top Industries:
18 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CELC Celcuity | Initiates Coverage On: Buy | 110 | 50.6 | 117.39% | 1 | Sep 22, 2025 | |
ORIC ORIC Pharmaceuticals | Assumes: Buy | 18 | 11.12 | 61.87% | 1 | Sep 4, 2025 | |
RLAY Relay Therapeutics | Assumes: Buy | 15 | 5.17 | 190.14% | 1 | Sep 4, 2025 | |
NUVL Nuvalent | Assumes: Buy | 122 | 81.39 | 49.9% | 1 | Sep 4, 2025 | |
CCCC C4 Therapeutics | Initiates Coverage On: Buy | 8 | 2.23 | 258.74% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 72 | 23.23 | 209.94% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 3.4 | 135.29% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 20.95 | 90.93% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 2.14 | 133.64% | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 150 | n/a | n/a | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 450 | 7.57 | 5844.52% | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 145 | n/a | n/a | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 55 | 16.6 | 231.33% | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 100 | n/a | n/a | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | n/a | n/a | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | 39.04 | -23.16% | 1 | Mar 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 78 | n/a | n/a | 1 | Mar 31, 2021 |